Zacks Research Has Positive Outlook for CLB Q1 Earnings

Core Laboratories Inc. (NYSE:CLB) – Investment analysts at Zacks Research raised their Q1 2028 earnings per share (EPS) estimates for shares of Core Laboratories in a research report issued to clients and investors on Wednesday, June 17th. Zacks Research analyst Team now anticipates that the oil and gas company will post earnings per share of $0.24 for the quarter, up from their previous estimate of $0.23. The consensus estimate for Core Laboratories’ current full-year earnings is $0.56 per share.

Other research analysts have also recently issued reports about the stock. Wall Street Zen cut shares of Core Laboratories from a “hold” rating to a “sell” rating in a research report on Monday, May 25th. Weiss Ratings lowered shares of Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Core Laboratories has a consensus rating of “Hold” and a consensus target price of $12.00.

Core Laboratories Stock Up 2.2%

Shares of NYSE:CLB opened at $11.68 on Friday. The company has a market capitalization of $538.49 million, a price-to-earnings ratio of 17.97, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. The company has a 50 day moving average of $14.53 and a two-hundred day moving average of $16.42. Core Laboratories has a 52-week low of $9.72 and a 52-week high of $20.36. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. The firm had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.Core Laboratories’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.14 EPS. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Core Laboratories by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after purchasing an additional 1,170 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Core Laboratories by 14.3% during the 2nd quarter. American Century Companies Inc. now owns 133,033 shares of the oil and gas company’s stock valued at $1,533,000 after buying an additional 16,677 shares during the last quarter. Quantbot Technologies LP grew its position in shares of Core Laboratories by 343.7% during the second quarter. Quantbot Technologies LP now owns 17,520 shares of the oil and gas company’s stock worth $202,000 after buying an additional 13,571 shares in the last quarter. Sei Investments Co. bought a new stake in shares of Core Laboratories in the second quarter worth $231,000. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Core Laboratories by 6.2% in the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock worth $207,000 after buying an additional 1,040 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Monday, May 11th were paid a $0.01 dividend. The ex-dividend date was Monday, May 11th. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. Core Laboratories’s payout ratio is 6.15%.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.